Catalyst Pharmaceuticals, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.
In the following Press release “Catalyst Pharmaceutical Partners, Inc. announced initial positive efficacy results from an investigator sponsored study of CPP-115 in an animal model of infantile spasms (IS).” Read the full article.
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette’s disorder. The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL. [Source: MarketWatch]
Company Website: http://www.catalystpharma.com